Items Tagged ‘lymphoblastic leukemia’

September 6th, 2016

Inotuzumab Ozogamicin Improves Progression-Free Survival in Acute Leukemia


The investigative agent, inotuzumab ozogamicin, significantly improves progression-free survival and 2-year survival rates among patients with acute lymphoblastic leukemia that has stopped responding to prior therapy. These results were recently published in the New England Journal of Medicine. Acute lymphoblastic leukemia (ALL) is an aggressive form of leukemia with limited treatment options once it progresses […]

View full entry

Tags: Acute Lymphoblastic Leukemia, all, inotuzumab ozogamicin, Leukemia, lymphoblastic leukemia, News